Koninklijke Philips N.V. (PHG) Análise de ações

Visão geral da empresa

Koninklijke Philips N.V. operates as a prominent health technology entity serving markets across North America, Greater China, and internationally through its Diagnosis & Treatment, Connected Care, and Personal Health segments, offering diagnostic imaging solutions and ultrasound capabilities. The company functions within the Healthcare sector specifically in the Medical Devices industry, an environment characterized by stringent regulatory requirements and significant capital investment in research and development. This industrial scale is substantiated by a market capitalization of $25.67B and an annual revenue base of $17.83B, supported by an organizational workforce of 61,085 employees. These valuation and revenue figures indicate that the entity maintains a substantial market footprint, positioning it as a major player capable of influencing industry standards while managing a complex global supply chain.

Saúde financeira

The financial performance of the company over the trailing twelve months is defined by a revenue generation of $17.83B, a net income of $899.00M, and an EBITDA of $2.02B. The substantial disparity between the total revenue of $17.83B and the net income of $899.00M reveals a cost structure where operating expenses, including cost of goods sold and overhead, consume approximately 95% of total sales before reaching the bottom line. The company generated $453.00M in free cash flow, which signifies a degree of financial flexibility allowing for operational reinvestment or debt servicing without relying solely on external financing. Profitability is assessed through three key margin metrics: a gross margin of 45.2%, an operating margin of 10.7%, and a profit margin of 5.0%, where the progression from gross to profit margin highlights the significant impact of operating expenditures on final earnings. Regarding capital structure, the company holds $2.79B in cash against $8.09B in debt, resulting in a debt-to-equity ratio of 73.57, which suggests a leveraged balance sheet where debt obligations significantly outweigh liquid cash reserves. Liquidity in the short term is supported by a current ratio of 1.32, indicating that current assets exceed current liabilities by a moderate margin sufficient to meet immediate obligations. Efficiency in capital deployment is measured by a return on equity of 7.8% and a return on assets of 3.2%, metrics that reveal management's effectiveness in generating returns relative to shareholder equity and the total asset base employed.

Avaliação de valorização

Valuation multiples for Koninklijke Philips N.V. currently stand at a P/E ratio of 25.03 on a trailing twelve-month basis and a forward P/E of 12.84, implying that the market expects a significant expansion in earnings relative to current historical levels. The price-to-book ratio is recorded at 2.01, indicating that the market values the company at more than double its net asset book value, suggesting a premium assigned to intangible assets and brand equity. Alternative valuation metrics include a price-to-sales ratio of 1.44 and an EV/EBITDA of 15.28, which provide context for value assessment independent of earnings volatility and capital structure leverage. In terms of trading range, the stock has experienced a 52-week high of $33.44 and a 52-week low of $21.48, with the current price position requiring calculation to determine its percentage distance from these extremes relative to the established volatility band. The stock exhibits a beta of 0.94, which indicates that its price volatility moves in close alignment with the broader market, exhibiting slightly lower sensitivity than the market average during periods of fluctuation.

Growth & Income

Revenue growth for the trailing twelve months is recorded at 1.1%, while earnings growth is listed as N/A in the available data, meaning a direct comparison of earnings velocity versus revenue velocity cannot be quantified for this specific period. The company maintains a dividend yield of 3.8% with a payout ratio of 91.7%, a high payout level that requires careful scrutiny regarding sustainability given the constraints on retained earnings available for reinvestment. The combination of a high payout ratio and modest revenue growth suggests that the company is distributing a large portion of its earnings to shareholders rather than aggressively reinvesting for organic expansion. Overall, the growth and income profile presents a mature asset with limited revenue expansion but a commitment to returning capital to investors through a substantial dividend yield.